Trials / Not Yet Recruiting
Not Yet RecruitingNCT07501065
Prophylactic Antibiotics for Outpatient Urethral Bulking
Prophylactic Antibiotics for Outpatient Urethral Bulking: Impact on Post-Procedural Urinary Tract Infection Rates
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether taking prophylactic (preventative) antibiotics at the time of standard of care clinic-based urethral bulking reduces the risk of post-procedural urinary tract infection (UTI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bactrim (800/160 mg) or Macrobid (100mg) | Participants will receive a single oral dose of either Bactrim (800 mg sulfamethoxazole + 160 mg trimethoprim) or if allergic to sulfonamides, a single oral dose of Macrobid (100 mg nitrofurantoin) at the time of the urethral bulking procedure. |
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2028-06-01
- Completion
- 2028-12-01
- First posted
- 2026-03-30
- Last updated
- 2026-03-30
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07501065. Inclusion in this directory is not an endorsement.